Article Details
Retrieved on: 2018-04-04 23:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>On April 5, 2018, PAVmed Inc. (the “Company”) completed an exchange offer (the “Offer”) to which the Company had offered to all holders of the Company's outstanding warrants to purchase shares of the Company's common <b>stock</b>, par value $0.001 per share (the “Common <b>Stock</b>”), issued to that certain ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here